CIOMS has published the draft report of Working Group XII on Benefit-Risk Assessment... Our latest #Pharmacovigilance Regulatory Intelligence Report is out ! Read the Highlights and sign up for Free Alerts... https://t.co/VcCSy8wPAs
The ICH E6(R3) draft Guideline on GCP has entered the public consultation period...
Our latest #Pharmacovigilance Regulatory Intelligence Report is out ! Read the Highlights and sign up for Free Alerts... https://t.co/VcCSy8wPAs
#Pharmacovigilance : What is the impact of the Reform of the EU Pharmaceutical Legislation ?
Read our article and don't forget to sign up for these alerts on our website...
https://t.co/O1TgAjPwKs
New MHRA GCP Inspections Metrics Report:
4 Critical Findings related to Pharmacovigilance...
Our latest #Pharmacovigilance Regulatory Intelligence Report is out ! Read the Highlights and sign up for Free Alerts... https://t.co/VcCSy8xnq0
New Q&A Document on the Clinical Trials Information System (CTIS) and the EU Clinical Trials Regulation...
Our latest #Pharmacovigilance Regulatory Intelligence Report is out ! Read the Highlights and sign up for Free Alerts... https://t.co/VcCSy8wPAs
New “quick guide for sponsors” to support compliance with the EU Clinical Trials Regulation...
Our latest #Pharmacovigilance Regulatory Intelligence Report is out ! Read the Highlights and sign up for Free Alerts... https://t.co/VcCSy8wPAs
The US FDA has published the final guidance entitled “Format and Content of a REMS Document”...
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for Free Alerts on our new website... https://t.co/VcCSy8wPAs
The Saudi FDA has published a revised version of its GVP Guideline, with some significant changes...
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for Free Alerts on our new website... https://t.co/VcCSy8xnq0
ICH E19 Guideline on optimization of Safety Data Collection finalised and adopted by EMA for Europe...
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for Free Alerts on our new website... https://t.co/VcCSy8xnq0
New FDA final guidance on RWD/RWE submissions...
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for free alerts on our new website... https://t.co/VcCSy8wPAs
A new FDA draft guidance explains how generic sponsors will be able to submit electronic Safety Reports to FAERS.
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for free alerts on our new website... https://t.co/VcCSy8wPAs
The EMA has published a list of metadata describing Real-World Data (RWD) sources and studies.
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for alerts on our new website... https://t.co/VcCSy8wPAs
#Pharmacovigilance : @ansm issues revised French GVPs
Read our article to find out about the main changes !
Don't forget to sign up for these alerts on our new website...
https://t.co/cLLIwdvYY3
#Pharmacovigilance : @ansm issues revised French GVPs
Read our article to find out about the main changes !
Don't forget to sign up for these alerts on our new website...
https://t.co/cLLIwdvYY3
New Q&As published on the New EU Clinical Trials Regulation.
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for alerts on our new website... https://t.co/VcCSy8wPAs
The FDA published the final guidance for the electronic submission of Postmarketing Safety Reports.
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for alerts on our new website... https://t.co/VcCSy8wPAs
Pharmacovigilance Inspections: Malaysian authorities issue guidance on voluntary GVP Inspections...
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for alerts on our new website... https://t.co/VcCSy8wPAs
Pharmacovigilance Inspections: Malaysian authorities issue guidance on voluntary GVP Inspections...
Check out our latest #Pharmacovigilance Regulatory Intelligence Report !
Read the Highlights and sign up for alerts on our new website... https://t.co/VcCSy8wPAs